India’s Finance Minister Accuses China of Blocking Indian Beef Exports as Trade Dispute Intensifies

Trade tensions between India and China have resurfaced after Indian Finance Minister Nirmala Sitharaman accused Beijing of restricting Indian exports through non-tariff barriers, including measures affecting bovine meat, generic medicines and agricultural products.

Speaking at an Atlantic Council event on the sidelines of the International Monetary Fund and World Bank annual meetings in Bangkok on October 16, Sitharaman argued that limited access to the Chinese market was contributing to India’s widening trade deficit. Her comments have renewed debate over market access, regulatory requirements and the future of economic ties between the two countries.

However, the minister’s remarks reflect India’s position on the trade dispute. The specific reasons individual products cannot enter a market, the legitimacy of relevant inspection requirements and the scope for resolving disagreements through technical negotiations must be assessed on a case-by-case basis.

Sitharaman Says Non-Tariff Barriers Restrict Indian Exports

During her interaction with the Atlantic Council, Sitharaman said India had spent years seeking greater access to the Chinese market but had made limited progress. She described non-tariff barriers as a major obstacle to bilateral trade, citing phytosanitary measures and other technical requirements.

The products she highlighted included generic medicines, bovine meat, vegetables and other agricultural goods that India believes have considerable export potential in China. Improving market access, she argued, would give Indian businesses more opportunities to expand overseas sales and help address the country’s persistent trade imbalance.

The reference to beef requires some qualification. Bovine meat covers different categories of animal products, and the minister’s remarks alone do not establish that China has imposed a blanket ban on every category of Indian beef. Import eligibility can depend on product classification, sanitary approval, food-safety requirements, exporter qualifications and bilateral regulatory arrangements.

Bilateral Trade Deficit Exceeds $100 Billion

Trade figures provide important context for India’s concerns. According to Chinese customs data, bilateral trade between China and India reached approximately $144.45 billion in the first nine months of 2026.

China’s exports to India totaled about $125.19 billion, while Indian exports to China reached approximately $19.26 billion. The resulting Indian trade deficit was around $105.93 billion.

The figures also showed that Indian exports to China increased by approximately 40.7% year on year, while Chinese exports to India rose by around 23.3%. Although Indian shipments grew considerably, the much larger volume of imports meant that the overall trade gap remained substantial.

A trade deficit alone does not establish that one side is engaging in unfair trade practices. Industrial structures, consumer demand, supply-chain relationships, price competitiveness and market-access rules can all influence the composition of bilateral trade. Strengthening domestic competitiveness while expanding exports remains a central challenge for India.

Beijing Says It Does Not Deliberately Seek a Trade Surplus

Responding to the criticism, Chinese Foreign Ministry spokesperson Mao Ning said China does not deliberately seek a trade surplus and is willing to work with India to address each other’s economic and trade concerns in a balanced manner.

The response emphasized dialogue and cooperation as the preferred means of managing differences. Resolving the specific concerns raised by India would require further discussions between the relevant authorities, including clarification of product categories, inspection procedures, risk assessments and applicable regulatory standards.

Food and agricultural trade commonly involves controls related to animal diseases, quarantine and consumer safety. Whether a particular measure complies with international rules and is applied transparently must be assessed using the relevant regulations and evidence, rather than inferred from the size of a trade deficit.

Market Access and Competitiveness Both Matter

India wants to expand exports of generic medicines, animal products and agricultural goods, while China must manage the safety and quarantine risks associated with imported products under its regulatory framework. These objectives are not necessarily incompatible, but turning potential demand into actual trade requires clear approval procedures, verifiable technical standards and effective communication.

For India, improving export access also means ensuring that products meet the importing market’s safety requirements and that exporters satisfy the necessary qualifications. For China, transparent rules, consistent enforcement and functioning consultation mechanisms can help reduce uncertainty for businesses.

Given the scale of China-India trade, disagreements over market access and the trade imbalance are likely to remain important issues. Rather than relying on mutual accusations, the two sides could make more progress by establishing clear technical channels for individual products, conducting regulatory assessments and addressing specific obstacles through negotiation.

The outcome of such efforts could influence not only agricultural and pharmaceutical trade but also the broader economic relationship between two of Asia’s largest economies.